"ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand.

Rani Therapeutics secured a $1.085 billion collaboration with Chugai Pharmaceutical. Check out why I am initiating with a Buy ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies, ...

Rani Therapeutics Holdings Inc. (NASDAQ:RANI) has signed a major collaboration agreement with Chugai Pharmaceutical Co. Ltd. ...

DAVIS, Calif.--(BUSINESS WIRE)--Botanical Solution, a leading producer of advanced botanical materials, has won two awards in the 2024 Pharmaceutical Technology Excellence Awards in the Innovation and ...

In this interview, Charles Chase, PhD, the VP and Technical Business Development at Asymchem, a technology-focused pharmaceutical manufacturing company, discusses the significant impact of RNA ...

MIT engineers developed a method to unstick cells using electrochemical bubbles, which can increase efficiency in various ...

Pharmaceutical industry leaders on Tuesday urged the Federal Government to prioritise pharmaceutical innovation, technology ...

Dynamic Vapor Sorption (DVS) is a potent analytical technique used in the pharmaceutical industry to determine how much vapor a sample absorbs or desorbed under regulated temperature and humidity ...

Experiment: Scientists work to synthesize drugs produced in part through space launches. (Photo c/o Varda) Varda Space Industries, based in El Segundo, makes drugs in space. But Will Bruey, Varda ...

Want to invite a colleague to this FREE webinar? Fill out the form below and we'll send your colleague an invitation to the "Enhancing Pharmaceutical Manufacturing Using Raman Spectroscopy" event.